Bruker 17. Apr. 2026 Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know - StockStory
Bruker 17. Apr. 2026 Bruker Launches MyGenius PRO Automated Molecular Diagnostics System in Europe - Contract Pharma
Bruker 17. Apr. 2026 Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026 - Nasdaq
Bruker 17. Apr. 2026 Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026 - Business Wire
Bruker 17. Apr. 2026 Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management - Yahoo Finance
Bruker 17. Apr. 2026 Bruker unveils spatial biology workflows, opens PaintScape pre-orders - Investing.com
Bruker 17. Apr. 2026 Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026 - Yahoo Finance
Bruker 17. Apr. 2026 Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026 - Yahoo Finance
Bruker 16. Apr. 2026 Bruker (BRKR) EVP Mark Munch sells 2,000 shares after option exercise - Stock Titan
Bruker 1. Apr. 2026 Bruker’s CellScape XR Targets Scalable Multiplexed Immunofluorescence Imaging - Genetic Engineering and Biotechnology News
Bruker 24. Feb. 2026 Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications - Business Wire
Bruker 24. Feb. 2026 Bruker advances Functional Proteomics 2.0 with timsOmni™ mass spectrometry proteoform analysis for deeper insights into disease biology - News-Medical
Bruker 23. Feb. 2026 Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum - Yahoo Finance
Bruker 9. Feb. 2026 Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC - Business Wire
Bruker 9. Feb. 2026 Bruker Introduces Label-Free Characterization Platform for Nanoscale Bioparticles - Contract Pharma